111 results
Page 3 of 6
6-K
EX-99.2
et190ah5st4 y0l
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
bqj5zp5xnp0vxfka0ya
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.3
opvyo1x938v24ns9m1x
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.4
0hik0xvj
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
ulldh x8twj
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
kfaj3fqgpa92s
8 Jun 22
KIMMTRAK is the first and only treatment approved in the UK, Australia, and Canada to treat patients with unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
agopgl asa0x
6 Jun 22
Immunocore presents new data on KIMMTRAK (tebentafusp-tebn) in metastatic
4:21pm
6-K
EX-99.1
nz5c dpj7l0478i8yr
3 Jun 22
Sanofi will evaluate KIMMTRAK in combination with SAR444245 as part of its ongoing Phase 1 study in advanced unresectable or metastatic skin cancers
4:05pm
6-K
EX-99.3
jwbiflo e1cyd3m7
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.1
t06ltc9 5e90ujigqw
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.2
h9k1790986cf3yuz0
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
424B7
gzhod 7zyp0
5 May 22
Prospectus with selling stockholder info
12:00am
6-K
EX-99.1
lxrgc swqjdhcv9
14 Apr 22
Current report (foreign)
4:11pm
F-3ASR
1yypv87
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
6-K
EX-99.1
hbwsfa
4 Apr 22
European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
j7hjkk2r7s7x2qd1gxk
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.2
ww9bta9o
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.1
wrlia
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
ts1nin8l
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am